Frédéric André DE CEUNINCK

City:

Paris

Country:

France

Published Applications:

Last publication date:

2021-10-07

Top Assignees for applications by Frédéric André DE CEUNINCK

The entities that hold a legal rights for patent applications filed by inventor DE CEUNINCK Frédéric André:

GALAPAGOS N.V. 6 Mechelen, Belgium
LES LABORATOIRES SERVIER 2 Suresnes, France
LES LABORATORIES SERVIER 1 SURESNES, France

Recent patent applications by DE CEUNINCK Frédéric André

Frédéric André DE CEUNINCK from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-10-07

US20210309614A1

Chemistry; metallurgy

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#2 | 2020-07-09

US20200216397A1

Chemistry; metallurgy

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#3 | 2019-10-17

US20190315719A1

Chemistry; metallurgy

5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis

#4 | 2019-10-03

US20190300503A1

Chemistry; metallurgy

5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis

#5 | 2018-09-13

US20180258052A1

Chemistry; metallurgy

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#6 | 2018-01-04

US20180002293A1

Chemistry; metallurgy

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

InventorID:

2080931 ⎘